You have 9 free searches left this month | for more free features.

primary hyperoxaluria 3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

Enrolling by invitation
  • Primary Hyperoxaluria Type 1 (PH1)
  • +5 more
  • San Francisco, California
  • +19 more
Jun 22, 2022

Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)

Active, not recruiting
  • Primary Hyperoxaluria Type 1 (PH1)
  • San Diego, California
  • +15 more
Mar 4, 2022

Hyperoxaluria, Primary Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes Strain HC-1)

Terminated
  • Hyperoxaluria, Primary
  • Oxabact OC5 - Oxalobacter formigenes Strain HC-1
  • Nashville, Tennessee
  • +7 more
Nov 11, 2021

Primary Hyperoxaluria Type 3 Trial in Worldwide (DCR-PHXC, Sterile Normal Saline (0.9% NaCl))

Completed
  • Primary Hyperoxaluria Type 3
  • Boston, Massachusetts
  • +5 more
Sep 9, 2021

Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

Available
  • Primary Hyperoxaluria Type 1 (PH1)
  • (no location specified)
Aug 7, 2023

Primary Hyperoxaluria Type 3 Trial in Worldwide

Recruiting
  • Primary Hyperoxaluria Type 3
    • Boston, Massachusetts
    • +12 more
    Nov 16, 2021

    Primary Hyperoxaluria Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes HC-1, Placebo)

    Completed
    • Primary Hyperoxaluria
    • Oxabact OC5 - Oxalobacter formigenes HC-1
    • Placebo
    • Nashville, Tennessee
    • +9 more
    Dec 9, 2021

    Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

    Recruiting
    • Cystinosis
    • Primary Hyperoxaluria
    • Diagnostic test
    • Hanover, Lower Saxony, Germany
      Screening Laboratory Hanover
    Apr 24, 2023

    Rare Kidney Stone Consortium Patient Registry

    Recruiting
    • Primary Hyperoxaluria
    • +3 more
      • Rochester, Minnesota
      • +3 more
      Aug 19, 2022

      PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

      Active, not recruiting
      • PH1
      • +4 more
      • Bordeaux, France
      • +8 more
      Jan 13, 2023

      Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

      Recruiting
      • Adenine Phosphoribosyltransferase Deficiency
      • +83 more
        • Bristol, South West, United Kingdom
          Zoe Plummer
        Sep 26, 2023

        Phenotyping of Primary Hyperoxaluria

        Recruiting
        • Primary Hyperoxaluria
          • Strasbourg, France
            Service de Néphrologie et Transplantation - Hôpitaux Universitai
          Oct 25, 2021

          Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)

          Completed
          • Primary Hyperoxaluria
          • Oxalobacter formigenes
          • Bonn, Germany
            Universitätsklinikum Bonn, Department of Paediatric Nephrology
          Dec 9, 2021

          Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

          Recruiting
          • Primary Hyperoxaluria Type 1
            • Phoenix, Arizona
            • +10 more
            Aug 11, 2022

            Baby Detect : Genomic Newborn Screening

            Recruiting
            • Congenital Adrenal Hyperplasia
            • +126 more
              • Liege, Wallonia, Belgium
                CRMN, Hôpital La Citadelle
              Jan 24, 2023

              Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 Trial in Worldwide (nedosiran)

              Not yet recruiting
              • Primary Hyperoxaluria
              • +2 more
              • (no location specified)
              Sep 8, 2021

              Rare Kidney Stone Consortium Biobank

              Recruiting
              • Primary Hyperoxaluria
              • +3 more
                • Rochester, Minnesota
                  Mayo Clinic
                Jul 8, 2021

                Primary Hyperoxaluria, Cystinuria, Adenine Phosphoribosyl Transferase Deficiency Trial in Rochester, New York, Reykjavik

                Completed
                • Primary Hyperoxaluria
                • +3 more
                • Health-related Quality of Life in Rare Kidney Stone Questionnaire
                • Rochester, Minnesota
                • +2 more
                Aug 31, 2022

                Primary Hyperoxaluria Trial in Paris (stiripentol (Diacomit))

                Completed
                • Primary Hyperoxaluria
                • stiripentol (Diacomit)
                • Paris, France
                • +2 more
                Mar 25, 2021

                Primary Knee Osteoarthritis Grade 3 - 4 Trial in Tbilisi (Lipocet® (food supplement), Lipocet Placebo)

                Completed
                • Primary Knee Osteoarthritis Grade 3 - 4
                • Lipocet® (food supplement)
                • Lipocet Placebo
                • Tbilisi, Georgia
                • +2 more
                Nov 10, 2023

                Prospective Research Rare Kidney Stones (ProRKS)

                Recruiting
                • Hyperoxaluria
                • +4 more
                  • Birmingham, Alabama
                  • +10 more
                  Nov 10, 2022

                  Dysmenorrhea Primary Trial (Diclofenac 1%, Diclofenac 3%, Placebo)

                  Not yet recruiting
                  • Dysmenorrhea Primary
                  • Diclofenac 1%
                  • +2 more
                  • (no location specified)
                  Mar 1, 2023

                  Primary Breast Cancer Trial (SPECT)

                  Not yet recruiting
                  • Primary Breast Cancer
                  • (no location specified)
                  Jun 19, 2023